UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 412

Sortiert nach

Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease

Digestive diseases (Basel), 2019-01, Vol.37 (1), p.63-68

2019

Link zum Volltext

Verfügbarkeit prüfen

Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2

Frontiers in neuroscience, 2023-03, Vol.17, p.1128157-1128157

Butterworth, Roger F

2023

Link zum Volltext

Verfügbarkeit prüfen

L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle

Canadian journal of gastroenterology & hepatology, 2019-01, Vol.2019, p.1-6

2019

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited

Metabolic brain disease, 2016-12, Vol.31 (6), p.1211-1215

Butterworth, Roger F.

2016

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiology of brain dysfunction in hyperammonemic syndromes: The many faces of glutamine

Molecular genetics and metabolism, 2014-09, Vol.113 (1-2), p.113-117

Butterworth, Roger F.

2014

Link zum Volltext

Verfügbarkeit prüfen

Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology

Drugs (New York, N.Y.), 2019-02, Vol.79 (Suppl 1), p.17-21

Butterworth, Roger F.

2019

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complications

PloS one, 2012-11, Vol.7 (11), p.e49670

2012

Link zum Volltext

Verfügbarkeit prüfen

Experimental models of hepatic encephalopathy: ISHEN guidelines

Liver international, 2009-07, Vol.29 (6), p.783-788

2009

Link zum Volltext

Verfügbarkeit prüfen

Metal Toxicity, Liver Disease and Neurodegeneration

Neurotoxicity research, 2010-07, Vol.18 (1), p.100-105

Butterworth, Roger F.

2010

Link zum Volltext

Verfügbarkeit prüfen

Hepatic encephalopathy: A central neuroinflammatory disorder?

Hepatology (Baltimore, Md.), 2011-04, Vol.53 (4), p.1372-1376

Butterworth, Roger F.

2011

Link zum Volltext

Verfügbarkeit prüfen

The liver-brain axis in liver failure: neuroinflammation and encephalopathy

Nature reviews. Gastroenterology & hepatology, 2013-09, Vol.10 (9), p.522

Butterworth, Roger F

2013

Link zum Volltext

Verfügbarkeit prüfen

P30 L-Ornithine L-Aspartate [LOLA] Improves Both Severe Encephalopathy and Survival in Patients With Liver Cirrhosis: Results of RCTs, Systematic Reviews and Meta-Analyses

The American journal of gastroenterology, 2023-09, Vol.118 (9S), p.S22-S22

Butterworth, Roger F.

2023

Link zum Volltext

Verfügbarkeit prüfen

Neuronal cell death in hepatic encephalopathy

Metabolic brain disease, 2007-12, Vol.22 (3-4), p.309-320

Butterworth, Roger F

2007

Link zum Volltext

Verfügbarkeit prüfen

Nutrition in the Management of Cirrhosis and its Neurological Complications

Journal of clinical and experimental hepatology, 2014-06, Vol.4 (2), p.141-150

2014

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiology of hepatic encephalopathy: The concept of synergism

Hepatology research, 2008-11, Vol.38 (s1), p.S116-S121

Butterworth, Roger F.

2008

Link zum Volltext

Verfügbarkeit prüfen

Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities

The Journal of steroid biochemistry and molecular biology, 2016-06, Vol.160, p.94-97

Butterworth, Roger F.

2016

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiology of hepatic encephalopathy: a new look at ammonia

Metabolic brain disease, 2002-12, Vol.17 (4), p.221-227

Butterworth, Roger F

2002

Link zum Volltext

Verfügbarkeit prüfen

Potential for the Repurposing of Adamantane Antivirals for COVID-19

Drugs in R&D, 2021-09, Vol.21 (3), p.267-272

Butterworth, Roger F.

2021

Link zum Volltext

Verfügbarkeit prüfen

Ammonia Removal by Metabolic Scavengers for the Prevention and Treatment of Hepatic Encephalopathy in Cirrhosis

Drugs in R&D, 2021-06, Vol.21 (2), p.123-132

Butterworth, Roger F.

2021

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of Hepatic Encephalopathy and Brain Edema in Acute Liver Failure

Journal of clinical and experimental hepatology, 2015-03, Vol.5 (Suppl 1), p.S96-S103

Butterworth, Roger F

2015

Link zum Volltext

Verfügbarkeit prüfen

Expression of astrocytic genes coding for proteins implicated in neural excitation and brain edema is altered after acute liver failure

Journal of neurochemistry, 2014-03, Vol.128 (5), p.617-627

2014

Link zum Volltext

Verfügbarkeit prüfen

Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysis

Metabolic brain disease, 2020-01, Vol.35 (1), p.75-81

Butterworth, Roger F.

2020

Link zum Volltext

Verfügbarkeit prüfen

l-Ornithine l-Aspartate (LOLA) for the Treatment of Hepatic Encephalopathy in Cirrhosis: Novel Insights and Translation to the Clinic

Drugs (New York, N.Y.), 2019-02, Vol.79 (Suppl 1), p.1-3

Butterworth, Roger F.

2019

Link zum Volltext

Verfügbarkeit prüfen

l-Ornithine l-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses

Drugs (New York, N.Y.), 2019-02, Vol.79 (Suppl 1), p.31-37

2019

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies

Journal of Hepatology, 2003-08, Vol.39 (2), p.278-285

Butterworth, Roger F

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 412

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(386)
Mit Volltextzugriff
(384)

Publikationsform

Sprache

Englisch
(412)
Japanisch
(59)

Erscheinungsjahr

n.n

Thema

Science & Technology
(277)
Life Sciences & Biomedicine
(274)
Animals
(186)
Biological And Medical Sciences
(173)
Humans
(166)
Neurosciences
(153)
Neurosciences & Neurology
(153)
Male
(146)
Medical Sciences
(130)
Rats
(115)
Hepatic Encephalopathy
(101)
Brain - Metabolism
(75)
Endocrinology & Metabolism
(71)
Biochemistry & Molecular Biology
(69)
Rats, Sprague-Dawley
(62)
Hepatic Encephalopathy - Metabolism
(60)
Ammonia
(59)
Neurology
(56)
Gastroenterology & Hepatology
(54)
Female
(53)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Metabolic Brain Disease
(68)
Neurochemistry International
(56)
Hepatology
(31)
Journal Of Neurochemistry
(26)
Anesthesia And Analgesia
(12)
Journal Of Hepatology
(12)
Neurochemical Research
(10)
Chest
(9)
Neuroscience Letters
(7)
Alcoholism, Clinical And Experimental Research
(6)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease

Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2

L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle

Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited

Pathophysiology of brain dysfunction in hyperammonemic syndromes: The many faces of glutamine

Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology

Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complications

Experimental models of hepatic encephalopathy: ISHEN guidelines

Metal Toxicity, Liver Disease and Neurodegeneration

Hepatic encephalopathy: A central neuroinflammatory disorder?

The liver-brain axis in liver failure: neuroinflammation and encephalopathy

P30 L-Ornithine L-Aspartate [LOLA] Improves Both Severe Encephalopathy and Survival in Patients With Liver Cirrhosis: Results of RCTs, Systematic Reviews and Meta-Analyses

Neuronal cell death in hepatic encephalopathy

Nutrition in the Management of Cirrhosis and its Neurological Complications

Pathophysiology of hepatic encephalopathy: The concept of synergism

Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities

Pathophysiology of hepatic encephalopathy: a new look at ammonia

Potential for the Repurposing of Adamantane Antivirals for COVID-19

Ammonia Removal by Metabolic Scavengers for the Prevention and Treatment of Hepatic Encephalopathy in Cirrhosis

Pathogenesis of Hepatic Encephalopathy and Brain Edema in Acute Liver Failure

Expression of astrocytic genes coding for proteins implicated in neural excitation and brain edema is altered after acute liver failure

Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysis

l-Ornithine l-Aspartate (LOLA) for the Treatment of Hepatic Encephalopathy in Cirrhosis: Novel Insights and Translation to the Clinic

l-Ornithine l-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses

Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies

Suchergebnisse filtern